image: Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoids system. Led by Editor-in-Chief Daniele Piomelli, Ph.D., Pharm.D., the Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Visit the Cannabis and Cannabinoid Research website to read the latest articles published in the journal. view more
Credit: ©Mary Ann Liebert, Inc., publishers
New Rochelle, NY, January 21, 2016--Cannabis and Cannabinoid Research the new peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers, announces a new partnership with The International Cannabinoid Research Society. This new collaboration promotes the missions of the Journal and Society to further the advancement of cannabis and cannabinoid-related research.
This new relationship reflects the growing need for education and broader dissemination of cannabis and cannabinoid biology research in the scientific and medical community, particularly in the face of the widespread changes to cannabis regulation worldwide. For over 25 years, the International Cannabinoid Research Society (ICRS) has been a leading society dedicated to education and scientific research in all fields of cannabis and cannabinoid research.
"The ICRS is delighted to affiliate with Cannabis and Cannabinoid Research and to collaborate with Mary Ann Liebert, Inc., to further the Society's educational objectives and support the dissemination of peer-reviewed cannabinoid research," says Cecilia J. Hillard, PhD, Executive Director of ICRS.
Led by Editor-in-Chief Daniele Piomelli, PhD, PharmD, Cannabis and Cannabinoid Research provides an important open access venue for publishing the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system. In addition to its collaboration with the ICRS, the Journal will publish the Society's 2016 Symposium abstracts. The ICRS 26th Annual Symposium will take place on June 27-30th, 2016, at the Bukovina Terma Hotel in Bukowina Tatrza?ska, Poland.
"We are excited to partner with the ICRS because they have a long history of facilitating scientific discussion and research on cannabis and cannabinoid science," says Jordan Schilling, Director of Open Access Publishing at Mary Ann Liebert, Inc. "Similarly, both Cannabis and Cannabinoid Research and the ICRS bring a diverse group of scientists and practitioners together not only to advance the science but also to share, learn and ultimately provide better education on cannabinoid research for medical application."
###
About the International Cannabinoid Research Society
The International Cannabinoid Research Society (ICRS) is a non-political, non-religious organization dedicated to scientific research in all fields of the cannabinoids, ranging from biochemical, chemical and physiological studies of the endogenous cannabinoid system to studies of the abuse potential of recreational Cannabis. In addition to acting as a source for impartial information on Cannabis and the cannabinoids, the main role of the ICRS is to provide an open forum for researchers to meet and discuss their research. More information can be found the ICRS website.
About the Journal
Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoids system. Led by Editor-in-Chief Daniele Piomelli, PhD, PharmD, the Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Visit the Cannabis and Cannabinoid Research website to read the latest articles published in the Journal.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Palliative Medicine, Journal of Alternative and Complementary Medicine, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.